29.5 C
Vientiane
Thursday, September 11, 2025
spot_img
Home Blog Page 363

ROLLER Launches Summer Ebook for Aspiring Attraction Entrepreneurs

From concept to business plan, ROLLER is helping aspiring operators with the ultimate guide to launching an attraction venue.

AUSTIN, Texas, Aug. 5, 2025 /PRNewswire/ — ROLLER, the all-in-one venue management platform for the leisure and attractions industry, has announced the launch of a new ebook titled “From Vision to Venue: An Entrepreneur’s Guide to Opening an Attraction Business.” The guide provides a comprehensive roadmap for aspiring venue owners looking to enter the fast-growing family entertainment market.

“When I first started in the industry, a guide like this would have saved me a lot of trial and error,” said Brett Sheridan, Field General Manager at ROLLER. “We created this resource to deliver genuinely useful intelligence to anyone looking to open a venue, whether you’re a seasoned operator or taking your very first steps. It breaks down what can feel overwhelming into a clear, practical roadmap.”

Key takeaways from the guide include:

  • How to assess market demand and identify the right business model for a chosen guest demographic
  • Methods for projecting capital expenditure and operating costs across real estate, equipment, and staffing
  • Step-by-step instructions for setting up venue operations, from hiring and training to maintenance and guest service
  • Strategies for marketing, brand-building, and optimizing the guest journey through technology
  • Tools for tracking performance, scaling sustainably, and exploring expansion or franchising options

The ebook is structured into four main sections: developing a business concept, managing capital expenditures, establishing operational systems, and planning for growth. It also includes practical templates and expert insights that will help operators get started with their concept.

“We know that no two journeys are the same, but the challenges operators face often are. When those moments come, when you’re trying to simplify the chaos or take things to the next level, we’re here to chat, share what we know, and help however we can,” said Sheridan.

The ebook is now available to download free of charge via the ROLLER website.

About ROLLER

ROLLER is the cloud-based venue management platform for modern attractions, purpose-built to remove friction from the guest experience at every touchpoint. The company’s all-in-one platform simplifies its customers’ business processes, improving efficiency and maximizing revenue. ROLLER’s comprehensive solution includes: Online Checkout & Ticketing, Point-of-Sale, Integrated Payments, Memberships, Gift Cards, Waivers, Self-Serve Kiosks, Cashless Wallets, Guest Surveys, and more. To learn more, visit roller.software.

Sanyou Bio Wins the “2025 Best Customer Satisfaction CRO Award”

SHANGHAI, Aug. 5, 2025 /PRNewswire/ — The highly anticipated 7th China Bio Innovation Expo was recently held in grand fashion in Suzhou. At the awards ceremony on August 1, Sanyou Bio was honored with the “2025 Best Customer Satisfaction CRO Award” in recognition of its deep expertise and outstanding performance in the field of preclinical research for new drug development. This prestigious award not only reflects the industry’s high regard for Sanyou Bio’s overall capabilities, but also serves as strong validation of the company’s unwavering commitment to driving innovation in biopharmaceutical R&D.

Winning the “2025 Best Customer Satisfaction CRO Award” award is a testament to Sanyou Bio’s past achievements and a powerful motivation for future growth. We sincerely thank our peers and partners across the industry for their continued trust and support. Sanyou Bio will remain true to its mission and continue forging ahead, striving for new milestones on the path of biopharmaceutical innovation.

About Sanyou Biopharmaceuticals

Sanyou Biopharmaceuticals is a cutting-edge antibody drug discovery and development company, featured by its super-trillion antibody library and its capability of both AI and wet-lab R&D platforms, with the mission of “making innovative biologics R&D easy for clients worldwide.”

Focusing on its intelligent super-trillion antibody library, Sanyou has built a world-leading, integrated and intelligent R&D platform for preclinical development of innovative biologics that seamlessly combines in silico and wet-lab capabilities. The company accelerates global new drug discovery and target research through four dimensions: new drug discovery, preclinical research, AI-driven drug development, and frontier scientific research.

Headquartered in Shanghai, China, Sanyou has subsidiaries in the United States, Europe, and other regions, with over 20,000 square meters of R&D and GMP-compliant facilities in operation or under development.

Sanyou offers its clients and partners a comprehensive “4C” service solution set that includes CRO, CDO, CPO (Collaborative Project Organization), and CRS (Core Reagent Solution) services. The company has established a global marketing network and formed strong partnerships with more than 1,200 pharmaceutical and biotech companies worldwide. It has successfully completed over 1,200 projects related to new drug discovery and development, more than 50 collaborative R&D projects, with 9 projects having completed IND submission.

Sanyou has been recognized as a National High-tech Enterprise, a Shanghai “Specialized and Innovative” Enterprise, a Shanghai “Little Giant” Enterprise, and a “Zhangjiang Star” Enterprise in Shanghai.

 

Southeast Asia Youth Join Global Innovation Movement at Xiamen University Malaysia


KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 5 August 2025 – The final competition and award ceremony of the Southeast Asia Division Contest of China International College Students’ Innovation Competition (SEA-CICSIC) 2025 and Malaysia-China Youth Innovation Competition (MCYIC) 2025 concluded successfully at Xiamen University Malaysia on 20 July 2025, bringing together young innovators from all over the Southeast Asia region to present and compete with their innovation ideas and projects.

Group photo of the top 5 winning teams with distinguished guests
Group photo of the top 5 winning teams with distinguished guests

With the Ministry of Education of China as the main organiser and Xiamen University China and Xiamen University Malaysia as co-organisers, the competition attracted over 1,200 students from 10 Southeast Asian countries (Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam), with projects covering topics such as sustainable technology, artificial intelligence, biotechnology, and social entrepreneurship.

Ultimately, 50 teams from 7 countries received awards, including 10 First Prize Awards, 15 Second Prize Awards, and 25 Third Prize Awards. These winning teams represented Xiamen University Malaysia, University of Malaya, Sampoerna University, the National University of Singapore, Cambodia University of Technology and Science (CamTech), and various universities across the region.

The outstanding projects will be recommended for participation in the 2025 China International College Students’ Innovation Competition finals. Minister-Counsellor Chen Youliang from the Embassy of the People’s Republic of China in Malaysia attended the ceremony and presented the awards.

Ms. Sun Yan, Executive President of the Promotion Association for Global Youth Innovation Leaders Community, noted that this was the first time a cross-regional sub-competition of the China International College Students’ Innovation Competition was held. She emphasized that this marks a new chapter for the event and addresses the pressing need for enhanced regional collaboration.

Associate Professor Zhang Ying, Vice President of Xiamen University Malaysia, stated that the university has long been committed to fostering students’ innovation abilities, and hopes that this event will strengthen people-to-people friendship between China and Southeast Asia, while promoting economic exchange with Southeast Asian countries.

Mr. Li Cheng, Deputy Director of the Academic Affairs Office at Xiamen University (China), delivered a speech on behalf of the university top management, emphasizing that the main campus and Malaysia campus will continue to deepen educational cooperation under the Belt and Road Initiative, promote science, technology, and talent exchange, and cultivate globally minded and innovative talent.

The China International College Students’ Innovation Competition is one of the world’s largest student innovation and entrepreneurship competitions. Since its inception in 2015, the competition has attracted millions of teams and tens of millions of participants from thousands of universities in over 100 countries spanning five continents.

The China–Malaysia Youth Innovation Competition, first launched in 2019, has now completed four successful editions. The event continues to garner strong participation from Malaysian students and has produced a number of notable outcomes.

The launching ceremony of this year’s competition took place on 25 April 2025, and was attended by Mr. Zheng Xuefang, Minister of the Chinese Embassy in Malaysia; Dato’ Abdul Majid Ahmad Khan, President of the Malaysia-China Friendship Association; Professor Li Cheng, Deputy Director of Academic Affairs at Xiamen University; and Mr. Zhu Lei, Executive President of the Global Youth Innovation Leadership Community Association.

Southeast Asia Youth Join Global Innovation Movement at XMUM
https://www.xmu.edu.my/2025/0724/c16257a492710/page.htm

Final Results of the Competition
https://events.xmu.edu.my/seacicsic25/result.html

Facebook- Xiamen University Malaysia
https://www.facebook.com/share/p/1HsQgVe53z/

Instagram- IEC Xiamen University Malaysia
https://www.instagram.com/p/DMelMfjyUlm/?img_index=1

Hashtag: #XiamenUniversityMalaysia

The issuer is solely responsible for the content of this announcement.

BeLive Technology Joins Forces with Insight Lab to Unlock Real-Time Viewer Insights Across Asia

SINGAPORE, Aug. 5, 2025 /PRNewswire/ — BeLive Holdings (NASDAQ: BLIV), a global interactive live streaming & video solutions provider, has entered a strategic partnership with one of Japan’s leading data strategy firms INSIGHT LAB Inc., to bring real-time analytics, AI, and personalized viewer engagement to the next level.

Through this partnership, INSIGHT LAB will serve as BeLive’s official “Data Strategy Partner,” leveraging and analyzing vast amounts of data generated by BeLive’s live streaming solutions to enable more advanced data-driven services for retail brands, hospitality groups, government agencies and other organizations.

Together, the companies will strive to co-innovate data-driven features that power personalization, predictive commerce, and smarter decision-making for public and private sectors alike.

In recent years, live streaming has rapidly expanded across industries—from retail and entertainment to education and government—as a key channel for communication, with growing emphasis on differentiated user experiences and two-way engagement.

Businesses are no longer using live streaming solely as a basic broadcasting tool to expand reach; they’re increasingly viewing it as a real-time touchpoint for customer understanding.

By combining BeLives scalable tech and UX expertise with INSIGHT LABs experience across 600+ data and AI projects, the partnership aims to bridge this gap, create new value in the live streaming space, and set a new standard for live, personalized, data-first experiences.

“In the era of data-driven business evolution, live streaming is a critical interface. Through our partnership with BeLive, we aim to deepen real-time customer understanding and enhance experience value, expanding the possibilities of data-driven business management,” said Isao Toyama, CEO of INSIGHT LAB Inc.

The scope of the partnership will include:

1. Data Strategy Consulting

  • Formulation of analytics strategies for real-time data generated from BeLive’s live streaming platform
  • Proposals for data utilization initiatives to analyze viewer behavior and optimize engagement

2. Scalable Data Infrastructure

  • Design and implementation of a unified data platform to manage high-volume live stream data
  • Real-time processing to enable instant stream optimization and dynamic decision-making

3. AI and Machine Learning Applications

  • Audience preference analysis and enhanced personalization features
  • Development of purchase prediction models for live stream commerce

4. Co-Developed Tools for Enterprises

  • Advanced performance measurement of live streaming campaigns
  • Joint development of marketing analytics tools for retail, education, and public sectors

5. Japan Market Expansion

  • INSIGHT LAB will serve as a local distributor and sales support for BeLive’s live streaming solutions
  • Rollout of customized, white-label live commerce platforms for Japanese enterprises

The two companies will also collaborate on initiatives such as joint development of AI models, data structuring and visualizing systems, and co-hosting seminars and sales activities focused in Japan and broader Asia.

“This partnership marks a major step forward for BeLive as we strive to personalize viewing experiences and create valuable feedback loops,” commented Kenneth Tan, CEO of BeLive Technology. “We look forward to leveraging INSIGHT LAB’s capabilities in data strategy and technology to deliver measurable business impact for our customers.”

About BeLive Technology

BeLive Technology is the leading provider of customized live streaming and video solutions in Southeast Asia. Headquartered in Singapore, the Company powers interactive video commerce experiences for brands, retailers, and platforms across global markets. With a scalable SaaS infrastructure and deep expertise in live engagement, BeLive enables businesses to leverage interactive live commerce for enhanced customer interaction, conversion, and brand loyalty, without the complexity of building their own infrastructure and technology stack. The company is IMDA SG Digital (SG:D) Accredited and live streams powered by BeLive have reached more than 100 million viewers worldwide, amounting to more than 50 million hours of content.

For more information, please visit: https://belive.technology

About INSIGHT LAB Inc.

INSIGHT LAB Inc. is a Tokyo-based data solutions company specializing in data strategy, analytics infrastructure, AI integration, and digital transformation. Since its founding in 2005, the company has supported over 600 organizations across industries by delivering end-to-end data services, from strategy formulation and data visualization to machine learning and predictive analytics.

With a nationwide presence and R&D centers in Niigata and other regional hubs, INSIGHT LAB combines technical expertise with local impact. Its team of certified engineers and consultants brings deep knowledge in BI tools, data platforms, and AI technologies.

INSIGHT LAB is a DX Certified Company under Japan’s Ministry of Economy, Trade and Industry (METI), recognized for advancing Digital Transformation (DX). It is also a Great Place to Work® and part of the J-Startup NIIGATA program, committed to making data accessible, actionable, and transformative for businesses and society.

To learn more, visit https://www.insight-lab.co.jp

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “aim,” “may, “will, “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics

  • Dr. Jong-Yoon Chun, Chairman and CEO of Seegene, highlights progress toward fully automated and data-driven molecular testing
  • Introduction of CURECA™, the first fully unattended PCR automation system, and STAgora™, a real-time global data analytics platform
  • Technologies designed to scale automation, enhance data insights, and support the company’s long-term vision of a world free from diseases

SEOUL, South Korea, Aug. 5, 2025 /PRNewswire/ — Seegene Inc., a global leader in molecular diagnostics, unveiled two new technologies at ADLM 2025 in Chicago (July 29–31) designed to advance laboratory automation and data-driven infectious disease monitoring. The company introduced CURECA™, world’s first fully unattended PCR automation system, and STAgora™, a real-time data analytics platform intended to support earlier detection and precision care.

[Photo 1] Seegene showcased its fully unattended PCR automation system, CURECA™, and infectious disease data analysis platform, STAgora™, at ADLM 2025 in Chicago, July 29-31, 2025 (local time).
[Photo 1] Seegene showcased its fully unattended PCR automation system, CURECA™, and infectious disease data analysis platform, STAgora™, at ADLM 2025 in Chicago, July 29-31, 2025 (local time).

Chairman Highlights Next Step in Molecular Diagnostics

“With CURECA™ and STAgora™, we are taking an important step toward the future of diagnostics,” said Dr. Jong-Yoon Chun, Chairman and CEO of Seegene, during a press conference with U.S. and global media on July 30. “Our goal is to enable laboratories worldwide to automate complex testing workflows and use diagnostic data more effectively, ultimately helping advance global efforts toward a world free from diseases.”

Today, most molecular testing systems remain only partially automated, dependent on skilled personnel for repetitive manual steps and fixed workflows that limit efficiency and scalability.

CURECA™ Breaks the Limits of Automation to Reshape Global Diagnostics

CURECA™ is the first system in the diagnostics industry designed to fully automate every step of PCR testing, including the traditionally manual pre-treatment stage. Seegene notes that achieving true full automation in diagnostics requires three key conditions: operation without highly trained professionals, continuous 24-hour processing, and uninterrupted specimen input. CURECA™ is designed to meet all three.

Its dedicated module, CURECA™ Prep, processes a wide range of specimen types such as urine, blood, sputum, and stool, addressing one of the most persistent barriers to automation. With the module handling diverse specimen pre-treatment, the full CURECA™ system completes the entire PCR workflow from sample loading through nucleic acid extraction, amplification, and result analysis without manual intervention. The system is engineered for continuous 24-hour operation, aiming to minimize human error, improve workflow efficiency, and allow laboratories to allocate skilled staff to higher-value activities.

Full automation has long been a challenge in diagnostics due to specimen variability and the reliance on trained personnel for repetitive pre-processing tasks. CURECA™ is intended to help laboratories overcome these constraints by providing a scalable and adaptable system that can be configured to fit different lab sizes and workflows. CURECA™ Prep could also potentially extend to other testing fields, such as clinical chemistry and immunodiagnostics, as Seegene continues to explore broader automation solutions.

[Photo 2] An attendee listens to a presentation on STAgora™ at Seegene’s booth at ADLM 2025 in Chicago.
[Photo 2] An attendee listens to a presentation on STAgora™ at Seegene’s booth at ADLM 2025 in Chicago.

STAgora™ Transforms Diagnostic Data into Real-Time Clinical Intelligence

STAgora™ is Seegene’s latest platform, designed to collect and analyze PCR testing data in real time, providing laboratories with broader context to inform diagnostic workflows. The platform includes more than 40 analytical tools, offering functions such as infection trend tracking, hospital-level positivity monitoring, and multi-pathogen co-infection pattern analysis. Rather than serving as a simple data repository, STAgora™ is built as an integrated platform intended to help laboratories derive meaningful, aggregated insights from testing data.

Today, individual test results often provide limited information without broader reference points. STAgora™ is designed to address this by enabling hospitals to build their own statistical datasets and compare aggregated data across institutions, helping them detect infection patterns faster and support more informed decision-making. The data shared through the platform is de-identified and formatted according to each institution’s requirements, supporting secure, real-time exchange at local, national, or global levels.

[Photo 3] Dr. Jong-Yoon Chun, Chairman and CEO of Seegene, presents CURECA™ and STAgora™ during a press conference at ADLM 2025 in Chicago on July 30, local time.
[Photo 3] Dr. Jong-Yoon Chun, Chairman and CEO of Seegene, presents CURECA™ and STAgora™ during a press conference at ADLM 2025 in Chicago on July 30, local time.

Advancing Toward a World Free from All Diseases

Dr. Chun reiterated Seegene’s long-term vision of building “a world free from diseases” noting that the introduction of CURECA™ and STAgora™ completes the company’s five core technology pillars. These include Seegene’s proprietary PCR technology, the SGDDS (Seegene Digitalized Development System) for automated assay development, its global Technology-Sharing Initiative, and now the addition of fully automated PCR testing and real-time data analytics capabilities.

Industry experts at ADLM 2025 expressed strong interest in Seegene’s new technologies. Jamel Giuma, President and CEO of Miami based laboratory IT consulting firm JTG Consulting Group, said, “I’ve attended many ADLM conferences over the years, and CURECA™ is one of the most innovative solutions I have seen so far. I believe it has the potential to simplify laboratory workflows, reduce the burden on lab personnel, and greatly enhance overall operational efficiency.”

“With CURECA™ and STAgora™, we’re addressing long-standing barriers in molecular diagnostics,” Dr. Chun added. “Just as smartphones and electric vehicles transformed their industries, we believe these technologies will redefine what is possible in diagnostic testing, helping laboratories worldwide achieve true automation, unlock the value of diagnostic data, and ultimately contribute to building a world free from diseases.”

Disclaimer

CURECA™ and STAgora™ demonstrated at ADLM 2025 are pre-commercial technologies under development, not commercially available, and are not currently cleared for clinical diagnostic use in any jurisdiction.

Ericsson Receives Frost & Sullivan’s 2025 Global SASE for the Distributed Enterprise Enabling Technology Leadership Recognition for Excellence in Cellular-Optimized Secure Networking

Recognized for driving digital innovation and customer success through unmatched application diversity, AI-driven automation, and a cellular-first strategy

SAN ANTONIO, Aug. 5, 2025 /PRNewswire/ — Frost & Sullivan has honored Ericsson with the 2025 Enabling Technology Leadership Recognition in the global SASE for the distributed enterprise industry for its outstanding achievements in digital innovation, customer-centric strategy execution, and secure networking leadership. This recognition highlights Ericsson Enterprise Wireless Solutions’ consistent leadership in driving measurable outcomes, strengthening its market position, and delivering customer-centric innovation in an evolving competitive landscape.

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. Ericsson Enterprise Wireless Solutions excelled in both, demonstrating its ability to align strategic initiatives with market demand while executing them with efficiency, consistency, and scale.

“Ericsson’s NetCloud SASE is fundamentally distinct from legacy SASE offerings. Rather than retrofitting traditional SD-WAN and security services into a cellular environment, Ericsson has built a platform from the ground up that embraces the unique demands of LTE and 5G networks. This cellular-optimized approach gives Ericsson a clear advantage in enterprise IoT-centric deployments, where fixed-line connectivity is either impractical, unavailable, or cost-prohibitive,” said Claudio Stahnke, Industry Analyst at Frost & Sullivan.

Guided by a long-term growth strategy focused on digital innovation and customer impact, Ericsson Enterprise Wireless Solutions has shown its ability to adapt and lead in a rapidly evolving landscape. The company’s strategic agility and sustained investment in cellular-first secure networking have enabled it to scale effectively across diverse global markets and industry verticals.

Innovation remains central to Ericsson’s approach. Its NetCloud SASE platform delivers a secure, zero trust foundation specifically optimized for LTE and 5G environments. NetCloud SASE combines AI-driven automation, unified management, and end-to-end visibility to address the operational constraints of lean IT teams and distributed enterprises.

Ericsson’s unwavering commitment to customer success strengthens its position in the market. Its global SASE solution enables users to create a zero trust network in less than six minutes, dramatically reducing provisioning time for sites, whether they be located in a branch, mobile vehicle, or IoT scenarios.  With flexible deployment models—cloud, hybrid, or on-premises—Ericsson supports a wide range of use cases across public safety, utilities, education, retail, and industrial sectors.

“We are honored to receive this recognition from Frost & Sullivan for our NetCloud SASE platform,” said Pankaj Malhotra, Head of Enterprise Networking and Security, Enterprise Wireless Solutions, Ericsson. “As a pioneer in Wireless WAN and known for the simplicity of our products, we are committed to making security and connectivity easy in some of the most challenging and important environments.”

Frost & Sullivan commends Ericsson for setting a high standard in competitive strategy, execution, and market responsiveness. The company’s vision, innovation pipeline, and customer-first culture are shaping the future of secure enterprise networking and driving tangible results at scale.

Each year, Frost & Sullivan presents the Enabling Technology Leadership Recognition to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. This recognizes forward-thinking organizations that are reshaping their industries through innovation and growth excellence.

Frost & Sullivan Best Practices Recognition

Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.
Contact us: Start the discussion.

Contact:

CamilaTinajero
E: camila.tinajero@frost.com

About Ericsson
Ericsson’s high-performing, programmable networks provide connectivity for billions of people every day. For nearly 150 years, we’ve been pioneers in creating technology for communication. We offer mobile communication and connectivity solutions for service providers and enterprises. Together with our customers and partners, we make the digital world of tomorrow a reality. www.ericsson.com

Contact:
bewspress@ericsson.com

BON Announces Reciept of Nasdaq Compliance Letter

XI’AN, China, Aug. 5, 2025 /PRNewswire/ — Bon Natural Life Limited (Nasdaq: BON) (“BON” or “the Company”), a leading provider of bio-ingredient solutions for the natural health and personal care industries, today announced reciept of compliance notification from the Nasdaq Stock Market LLC.

As previously reported on a Form 6-K filed with the U.S. Securities and Exchange Commission on July 11, 2025, Bon Natural Life Limited ( “the Company”) received notification from the Nasdaq Hearings Panel (the “Panel”) that the Company had regained compliance with Listing Rule 5550(a)(2) (the “Bid Price Rule”). The Panel also advised the Company that it will be subject to a one-year Discretionary Panel Monitor.

On July 29, 2025, the Company received notification from The Nasdaq Stock Market LLC confirming the Panel’s decision and stating that the matter is now closed.

About Bon Natural Life Limited (“BON”)
BON is a Cayman Islands company engaged in the business of natural, health, and personal care industries. For more information, please visit http://www.bnlus.com.

For more information, please contact:
Cindy Liu | IR  
Email: bonnatural@appchem.cn 

Safe Harbor Statement
This press release contains certain statements that may include “forward-looking statements.” All statements other than statements of historical fact included herein are “forward-looking statements.” These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,””expects” or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov).  All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

Neopharma Technologies Appoints Exchange Listing to Manage U.S. IPO

NEW YORK, Aug. 5, 2025 /PRNewswire/ — Neopharma Technologies Ltd (NTL), a leading MedTech company specializing in digital drug and impairment testing for workplace and public safety, has appointed Exchange Listing, LLC to manage its upcoming U.S. initial public offering (IPO), with plans to list on the NASDAQ Stock Exchange.

Neopharma has developed NEOVAULT®, the world’s first integrated chain-of-custody and data management platform for point-of-care (POC) drug testing. Paired with its NEOTEST® range of regulatory-grade oral and urine screening devices, NEOVAULT® provides a secure, mobile-enabled solution that supports compliance and operational safety for enterprises, governments, and healthcare organizations.

The company is uniquely aligned with emerging global policy. In April 2025, the White House Office of National Drug Control Policy formally endorsed the adoption of AI-powered digital drug testing technologies. NEOVAULT® is among the few globally certified platforms meeting this standard and is the only solution currently certified under HIPAA, SOC 2 Type 2, GDPR, and ISO 27001.

Commercial adoption is accelerating. Neopharma is in advanced agreement or active negotiation with:

  • Four of the world’s largest Drugs of Abuse (DOA) test kit manufacturers to NEOVAULT®-enable more than 150 million drug test kits
  • Multiple international distributors
  • 25 enterprise clients across Australia and New Zealand

This foundation supports a high-margin, recurring revenue model through SaaS and platform licensing.

Peter Goldstein, CEO of Exchange Listing, said:

“Neopharma’s platform, business model, and traction make it an ideal candidate for the U.S. capital markets. We’re confident in Shaun and Marcus’s leadership and committed to guiding the company through a successful Nasdaq listing aligned with its long-term growth strategy.”

Shaun Melville, Executive Director of Neopharma Technologies, added:

“Exchange Listing brings the IPO expertise and strategic insight we need as we expand globally. NEOVAULT® is solving real compliance and public safety challenges. We’re ready to scale this solution worldwide.”

About Neopharma Technologies Ltd

Neopharma Technologies delivers digital solutions for secure, real-time drug screening and compliance management. Its NEOVAULT® platform and NEOTEST® devices serve enterprise, healthcare, and government clients worldwide.

About Exchange Listing, LLC

Exchange Listing provides capital markets advisory and IPO readiness services for growth-stage companies targeting listings on the Nasdaq and NYSE.

Press Contact: enquiries@neopharmatechnologies.com

CONTACT: Shaun Melville, shaun@neopharmatechnologies.com